Last reviewed · How we verify
Drug-induced mucositis
Approved treatments
- Kepivance · Biovitrum Ab
Kepivance works by binding to fibroblast growth factor receptor 2, stimulating the growth and proliferation of mucosal cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Drug-induced mucositis patent landscape — cliff calendar, originator estates, attackable patents
- Drug-induced mucositis treatment landscape brief
- Drug-induced mucositis treatment updates RSS
Frequently asked questions about Drug-induced mucositis
What drugs treat Drug-induced mucositis?
Tracked treatments include Kepivance.
What is the treatment for Drug-induced mucositis?
Standard treatment for Drug-induced mucositis includes Kepivance. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Drug-induced mucositis patent cliff · Drug-induced mucositis CI report
- Treatment: Kepivance · Biovitrum Ab
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing